Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
17.65
+0.35 (2.02%)
Nov 9, 2026, 9:50 AM EST - Market open
Ardent Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 6,454 | 6,324 | 5,966 | 5,409 | 5,130 | 4,870 |
| 6,454 | 6,324 | 5,966 | 5,409 | 5,130 | 4,870 | |
Revenue Growth | 2.03% | 6.00% | 10.29% | 5.45% | 5.32% | 17.02% |
Cost of Revenue | 2,637 | 2,658 | 2,535 | 2,384 | 2,412 | 2,294 |
Gross Profit | 3,817 | 3,667 | 3,431 | 3,025 | 2,718 | 2,576 |
Selling, General & Admin | 2,657 | 2,538 | 2,383 | 2,217 | 1,915 | 1,765 |
Other Operating Expenses | 656.93 | 647.31 | 496.22 | 451.74 | 464.41 | 370.36 |
Operating Expenses | 3,480 | 3,341 | 3,026 | 2,810 | 2,518 | 2,273 |
Operating Income | 336.78 | 325.58 | 405.76 | 215.84 | 200.25 | 303.17 |
Interest Expense | -52.48 | -55.2 | -65.58 | -74.31 | -82.05 | -93.83 |
Other Non Operating Income (Expenses) | -14.64 | 1.8 | -0.12 | - | 3.39 | 0.1 |
EBT Excluding Unusual Items | 269.67 | 272.18 | 340.06 | 141.54 | 121.6 | 209.44 |
Gain (Loss) on Sale of Assets | - | - | - | - | 157.81 | - |
Other Unusual Items | -1.13 | -8.47 | 1.52 | 10.08 | 32.08 | 86.45 |
Pretax Income | 291.19 | 286.36 | 363.06 | 151.61 | 311.48 | 295.89 |
Income Tax Expense | 60.36 | 56.22 | 63.35 | 22.64 | 46.11 | 51.31 |
Earnings From Continuing Operations | 230.83 | 230.14 | 299.71 | 128.98 | 265.37 | 244.58 |
Net Income to Company | 230.83 | 230.14 | 299.71 | 128.98 | 265.37 | 244.58 |
Minority Interest in Earnings | -84.61 | -94.32 | -89.37 | -75.07 | -76.46 | -90.32 |
Net Income | 146.22 | 135.81 | 210.34 | 53.9 | 188.91 | 154.26 |
Net Income to Common | 146.22 | 135.81 | 210.34 | 53.9 | 188.91 | 154.26 |
Net Income Growth | -28.69% | -35.43% | 290.22% | -71.47% | 22.46% | - |
Shares Outstanding (Basic) | 141 | 141 | 132 | 126 | 126 | - |
Shares Outstanding (Diluted) | 142 | 141 | 133 | 126 | 126 | - |
Shares Change | 0.65% | 6.56% | 5.26% | - | -73.38% | - |
EPS (Basic) | 1.04 | 0.96 | 1.59 | 0.43 | 1.50 | - |
EPS (Diluted) | 1.03 | 0.96 | 1.58 | 0.43 | 1.50 | - |
EPS Growth | -28.72% | -39.24% | 269.66% | -71.47% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 282.3 | 258.61 | 127.52 | 84.29 | -189.47 | 7.91 |
Free Cash Flow Per Share | 1.99 | 1.83 | 0.96 | 0.67 | -1.50 | - |
Gross Margin | 59.14% | 57.98% | 57.51% | 55.93% | 52.99% | 52.89% |
Operating Margin | 5.22% | 5.15% | 6.80% | 3.99% | 3.90% | 6.22% |
Profit Margin | 2.27% | 2.15% | 3.53% | 1.00% | 3.68% | 3.17% |
Free Cash Flow Margin | 4.37% | 4.09% | 2.14% | 1.56% | -3.69% | 0.16% |
EBITDA | 503.2 | 481.29 | 552.05 | 356.69 | 338.43 | 440.38 |
EBITDA Margin | 7.80% | 7.61% | 9.25% | 6.59% | 6.60% | 9.04% |
D&A For EBITDA | 166.42 | 155.7 | 146.29 | 140.84 | 138.17 | 137.2 |
EBIT | 336.78 | 325.58 | 405.76 | 215.84 | 200.25 | 303.17 |
EBIT Margin | 5.22% | 5.15% | 6.80% | 3.99% | 3.90% | 6.22% |
Effective Tax Rate | 20.73% | 19.63% | 17.45% | 14.93% | 14.80% | 17.34% |